For pediatric patients aged 9 to 14 years with suspected opiate overdose, which Naloxone dose is correct?

Prepare for the ICEMA Medication Standing Orders Test. Hone your knowledge with questions and detailed explanations on various medications and protocols. Excel on your exam!

Multiple Choice

For pediatric patients aged 9 to 14 years with suspected opiate overdose, which Naloxone dose is correct?

Explanation:
Naloxone dosing in school‑age children is often set as a practical, fixed starting dose across common routes to ensure rapid and reliable reversal while keeping administration simple. For kids aged 9 to 14, a 0.5 mg dose given by IM, IN, IV, or IO provides a reliable initial reversal with a lower risk of overshoot compared with higher starting doses, and it allows responders to be watched closely with the option to give additional doses if needed. If the first 0.5 mg does not produce adequate improvement in respiratory effort, repeat 0.5 mg every 2–3 minutes while continuing supportive care. Weight-based dosing exists (0.1 mg/kg), but in this age group many protocols adopt the fixed 0.5 mg dose for practicality and consistency across routes. Lower starting doses could require multiple repeats and delaying reversal, while higher starting doses aren’t usually necessary initially in this population.

Naloxone dosing in school‑age children is often set as a practical, fixed starting dose across common routes to ensure rapid and reliable reversal while keeping administration simple. For kids aged 9 to 14, a 0.5 mg dose given by IM, IN, IV, or IO provides a reliable initial reversal with a lower risk of overshoot compared with higher starting doses, and it allows responders to be watched closely with the option to give additional doses if needed.

If the first 0.5 mg does not produce adequate improvement in respiratory effort, repeat 0.5 mg every 2–3 minutes while continuing supportive care. Weight-based dosing exists (0.1 mg/kg), but in this age group many protocols adopt the fixed 0.5 mg dose for practicality and consistency across routes. Lower starting doses could require multiple repeats and delaying reversal, while higher starting doses aren’t usually necessary initially in this population.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy